Branded Generics Market: By Type; By Applications:; By Distribution; By Geography & Forecast - Forecast 2016 -2021

  • ID: 3973933
  • Report
  • 150 pages
  • IndustryARC
1 of 3
Branded generics drugs are similar to the innovator products but are marketed and sold under different brand names. The color, size and shape of the brands of the same medicine may vary depending on the manufacturing company. Branded generics cover a broad range of treatments including antibiotics, antifungal medications and diabetic therapies among many others. Global market for branded generics is witnessing a significant growth in near future as numerous pharmaceutical products are going to be of patent in the coming years. Branded generics find the new ways to formulate drugs that have lost patent protection. Branded generics in emerging markets offer big pharmaceutical plays a viable growth. It assures consumers that the medicines are proven to be safe and effective. Generic drugs are less expensive and time consuming for their development. Branded generic drugs are used to treat hypertension, diabetes, back pain, arthritis, and thyroid disfunctioniong and others.

This report segments the branded generics market by type, by application and by distribution. Branded generics are of two major types; value added branded generics and trade named branded generics. By application, the market is classified into cardiovascular drugs, anti-cancer drugs, CNS drugs, and anti-infective drugs. By distribution, the market for branded generics includes retail pharmacies, hospital pharmacies and clinics.

The overall branded generics market is also studied for different region and their major countries. North America is the largest market due to its increasing demand for cost effective medicines followed by Europe, APAC and RoW. Branded generics market is poised to reach $XXm at a CAGR of XX% in the forecast period. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi, Astra Zeneca, Pupin Pharmaceuticals, Hospira Inc. are the renowned companies manufacturing Branded generics drugs.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Branded Generics Market Overview

2. Branded Generics Market- Executive Summary

3. Branded Generics Market Landscape
3.1. Market share Analysis
3.2. Product Benchmarking
3.3. Top 5 Financial Analysis

4. Branded Generics Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Market Attractiveness
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Branded Generics Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis

6. Branded Generics Market- By Type
6.1. Value Added Branded Generics
6.2. Trade Named Branded Generics

7. Branded Generics Market –By Application
7.1. Cardiovascular Drugs
7.2. Anti-Cancer Drugs
7.3. CNS Drugs
7.4. Anti-Infective Drugs
7.5. Others

8. Branded Generics Market- By Distribution
8.1. Retail Pharmacy & Drug Stores
8.2. Clinics
8.3. Hospital Pharmacies

9. Branded Generics Market – By Geography
9.1. Introduction
9.2. Americas
9.2.1. U.S.
9.2.2. Brazil
9.2.3. Mexico
9.2.4. Canada
9.2.5. Others
9.3. Europe
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Others
9.4. APAC
9.4.1. China
9.4.2. India
9.4.3. Australia
9.4.4. Japan
9.4.5. Others
9.5. RoW
9.5.1. Middle East
9.5.2. Africa

10. Branded Generics Market Patent Analysis

11. Branded Generics Market Company Profiles
11.1. Teva Pharmaceuticals Industries Ltd. (Israel)
11.2. Mylan N.V. (U.S.)
11.3. Hospira Inc. (U.S.)
11.4. Astra Zeneca (U.K.)
11.5. Sanofi SA (France)
11.6. Lupin Pharmaceuticals (India)
11.7. Zydus Cadila (India)
11.8. Valeant Pharmaceuticals (Canada)
11.9. GlaxoSmithKline Pharmaceuticals Limited (India
11.10. Apotex Inc. (Canada)
11.11. Dr. Reddys Laboratories Ltd. (India)
*More than 40 Companies are profiled in this Research Report, Complete List available on Request
*Financials would be provided on a best efforts basis for private companies

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll